Compare

Cellectar Biosciences, Inc. vs Cingulate Inc. vs Biovie Inc. vs Reviva Pharmaceuticals Holdings, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Cellectar Biosciences, Inc. CLRB	Cingulate Inc. CING	Biovie Inc. BIVI	Reviva Pharmaceuticals Holdings, Inc. RVPH
Year ended	2025-12-31	2025-12-31	2026-06-30	2025-12-31
Revenue	n/a	n/a	n/a	n/a
Revenue growth (YoY)	n/a	n/a	n/a	n/a
Gross margin	n/a	n/a	n/a	n/a
Operating margin	n/a	n/a	n/a	n/a
Net margin	n/a	n/a	n/a	n/a
Net income	-$21.79M	-$22.45M	-$22.07M	-$19.86M
EPS (Diluted)	-$8.35	-$4.44	-$3.05	n/a
Operating cash flow	-$23.12M	-$17.25M	-$19.02M	-$24.59M
Free cash flow	-$23.12M	-$17.41M	n/a	n/a
Cash & equivalents	$13.20M	$10.95M	$8.98M	$14.44M
Total assets	$14.98M	$15.07M	$14.25M	$15.92M
Total liabilities	$5.06M	$12.56M	$3.98M	$7.28M
Shareholders' equity	$8.54M	$2.51M	$10.27M	$8.65M
Return on year-end equity	-255.2%	-894.8%	-214.9%	-229.7%
Shares outstanding	4.24M	7.25M	7.54M	5.87M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Cellectar Biosciences, Inc.	Cingulate Inc.	Biovie Inc.	Reviva Pharmaceuticals Holdings, Inc.
Latest	n/a	n/a	n/a	n/a
1 year earlier	n/a	n/a	n/a	n/a
2 years earlier	n/a	n/a	n/a	n/a
3 years earlier	n/a	n/a	n/a	n/a
4 years earlier	n/a	n/a	n/a	n/a